antipyrine has been researched along with Cholelithiasis in 5 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
Cholelithiasis: Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Plasma antipyrine half-lives and metabolic clearances were measured after a single oral dose of antipyrine in 10 control subjects, 12 patients with gallstones, and 9 patients having undergone cholecystectomy for cholesterol cholelithiasis, to determine whether impairment of hepatic antipyrine metabolism occurs in patients with cholesterol cholelithiasis." | 7.65 | Normal antipyrine metabolism in patients with cholesterol cholelithiasis. Evidence that the disease is not due to generalized hepatic microsomal dysfunction. ( Hepner, GW; Vesell, ES, 1975) |
| "Plasma antipyrine half-lives and metabolic clearances were measured after a single oral dose of antipyrine in 10 control subjects, 12 patients with gallstones, and 9 patients having undergone cholecystectomy for cholesterol cholelithiasis, to determine whether impairment of hepatic antipyrine metabolism occurs in patients with cholesterol cholelithiasis." | 3.65 | Normal antipyrine metabolism in patients with cholesterol cholelithiasis. Evidence that the disease is not due to generalized hepatic microsomal dysfunction. ( Hepner, GW; Vesell, ES, 1975) |
| "In 22 patients with acute pancreatitis caused by biliary calculi and 9 healthy controls the rate of hepatic elimination of phenazone was measured." | 1.28 | [Effect of acute biliary pancreatitis on liver metabolism of phenazone]. ( Becker, A; Hartleb, M; Kacperek, T; Mańczyk, I; Nowak, A; Nowakowska-Duława, E, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| COSIN, M | 1 |
| FERRERAS, E | 1 |
| KOCK, NG | 1 |
| SVIRCEVIC, A | 1 |
| TEPAVCEVIC, P | 1 |
| KOVAC, T | 1 |
| Hepner, GW | 1 |
| Vesell, ES | 1 |
| Hartleb, M | 1 |
| Nowak, A | 1 |
| Nowakowska-Duława, E | 1 |
| Mańczyk, I | 1 |
| Becker, A | 1 |
| Kacperek, T | 1 |
5 other studies available for antipyrine and Cholelithiasis
| Article | Year |
|---|---|
[Clinico-experimental study with a new spasmolytic-analgesic preparation, Ro 4-4395].
Topics: Analgesics; Antipyrine; Biliary Dyskinesia; Chlordiazepoxide; Cholelithiasis; Deglutition Disorders; | 1963 |
[Palerol comp. in acute pain from gallstones and renal calculi].
Topics: Acute Pain; Analgesics; Analgesics, Non-Narcotic; Antipyretics; Antipyrine; Cholelithiasis; Dipyrone | 1963 |
[EXPERIENCES IN THE USE OF AVAFORTAN, A SPASMO-ANALGESIC AGENT].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Antipyrine; Biliary Dyskinesia; Cholecystitis; C | 1965 |
Normal antipyrine metabolism in patients with cholesterol cholelithiasis. Evidence that the disease is not due to generalized hepatic microsomal dysfunction.
Topics: Adult; Aged; Antipyrine; Cholecystectomy; Cholelithiasis; Cholesterol; Female; Half-Life; Humans; Li | 1975 |
[Effect of acute biliary pancreatitis on liver metabolism of phenazone].
Topics: Acute Disease; Adult; Aged; Antipyrine; Biotransformation; Cholelithiasis; Female; Humans; Liver; Li | 1990 |